IDH Wild-type and STAT3-positive Glioblastoma Clinical Trials in Florence, Italia/FI

Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients